首页> 外国专利> ORAL COMPOSITIONS AND ROUTE OF ADMINISTRATION FOR THE DELIVERY OF A THYLAKOID EXTRACT

ORAL COMPOSITIONS AND ROUTE OF ADMINISTRATION FOR THE DELIVERY OF A THYLAKOID EXTRACT

机译:口服类固醇提取物的口服成分和给药途径

摘要

The present invention provides a new use or method of use of a thylakoid extract, for oral route of administration, and a composition comprising the thylakoid extract in adjunction with an acceptable carrier for oral administration. Besides the pharmaceutical use, the thylakoid extract enters the composition of food or food supplements, or medication for its innocuity and its capacity to provide a diet enriched in anti-oxidants and anti-inflammatory compounds. Therefore, in accordance with the present invention is provided the use of athylakoid extract in the making of an oral composition for treating preventing a disease or disorder involving the formation of reactive oxygen species or inflammation . Also is provided a method for treating or preventing a disease or disorder involving the formation of reactive oxygen species inflammation in an individual, which comprises the step of orality administering an effective dose of a thylakoid extact. Further is provided an oral composition comprising a thylakoid extract and a vehicle for oral ingestion or oral administration. An oral composition comprising purified thylakoids and a carrier for oral ingestion or oral administration, with the proviso that the carrier does not essentially consists of water, physiological saline or propylene glycol is also provided as food or a food supplement, or as a peliet, or encapsulated granules or powder. The carrier may be present in an amount of 0.01% to 95% (w/w) of the total composition. The purified thylakoids are present in an amount which achieves a dosage of 0.1 to 10 mg per Kg of a subject's body weight.
机译:本发明提供类囊体提取物用于口服给药途径的新用途或使用方法,以及包含类囊体提取物与可接受载体一起用于口服给药的组合物。除药物用途外,类囊体提取物由于其无毒且具有提供富含抗氧化剂和抗炎化合物的饮食的能力而进入食品或食品补充剂或药物的组合物中。因此,根据本发明,提供了类胡萝卜素提取物在制备口服组合物中的用途,所述口服组合物用于治疗预防涉及活性氧物质的形成或炎症的疾病或病症。还提供了一种用于治疗或预防涉及在个体中形成反应性氧物种炎症的疾病或病症的方法,其包括口服施用有效剂量的类囊体提取物的步骤。还提供了包含类囊体提取物和用于口服摄取或口服施用的媒介物的口服组合物。还提供了包含纯化的类囊体和用于口服摄入或口服的载体的口服组合物,条件是该载体基本上不由水,生理盐水或丙二醇组成,也可以作为食品或食品补充剂或作为颗粒使用,或包封的颗粒或粉末。载体可以以总组合物的0.01%至95%(w / w)的量存在。纯化的类囊体的存在量达到每公斤受试者体重0.1至10 mg的剂量。

著录项

  • 公开/公告号US2019240276A1

    专利类型

  • 公开/公告日2019-08-08

    原文格式PDF

  • 申请/专利权人 GROUPE SANTÉ DEVONIAN;

    申请/专利号US201816159364

  • 发明设计人 MARC PURCELL;RÉJEAN DROUIN;

    申请日2018-10-12

  • 分类号A61K36/21;A61K9;A23L33/105;A61K36;

  • 国家 US

  • 入库时间 2022-08-21 12:06:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号